Pathological Gambling Clinical Trial
Official title:
Evaluating the Benefits of the Community Reinforcement and Family Training(CRAFT) Approach to Concerned Significant Others(CSO) of Individuals Engaged in Problem Gambling (IPGs)
NCT number | NCT01340274 |
Other study ID # | 001 |
Secondary ID | |
Status | Withdrawn |
Phase | Phase 2 |
First received | |
Last updated | |
Start date | June 3, 2011 |
Est. completion date | April 15, 2012 |
Verified date | April 2011 |
Source | Colchester East Hants Health Authority |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Nova Scotia is experiencing a proliferation of gambling opportunities and their related
gambling problems. The 2003 Nova Scotia Prevalence Study (2004) found that approximately
50,000 adult Nova Scotians are at some risk for problem gambling and that approximately
93,000 adult Nova Scotians are intimately connected to at least one person who has a gambling
problem. The serious consequences of problem gambling are being felt by the Individuals
engaging in Problem Gambling (IPGs), their Concerned Significant Others (CSOs) and their
Communities.
Very few IPGs access support services for their gambling problems. Some reports (National
Gambling Impact Study Commission 1999) have found that only 3% of IPGs seek treatment. The
Nova Scotia Gambling Prevalence Study (2004) states: "Overall, 3.5% (26,000 adults) have been
motivated to help someone else with a current gambling problem versus 0.5% (3,700 adults)
seeking assistance or information for a personal problem". While the CSOs of IPGs are seven
times more likely to access professional addiction treatment the options for these
individuals are limited and treatment programs often lack evidence in support of their
effectiveness.
The Community Reinforcement and Family Training (CRAFT) (Meyers & Wolfe 2004) approach
provides significant benefits to the CSOs of persons abusing alcohol and other drugs. They
benefits include: improvement in the quality of life of the CSOs; increasing the rate of
substance abusers entering treatment; and decreased substance use. CRAFT empowers CSOs by
providing tools to positively influence theirs and their significant other's behavior.
The current study investigates the applicability and effectiveness of the CRAFT approach to
the CSOs of IPGS.
It is predicted that benefits to the CSOs receiving CRAFT will significantly surpass those
receiving treatment as usual. The predicted benefits are: improvement in quality of life for
the CSO; engagement of IPGs in treatment; and decreased gambling by the IPGs. With these
achieved outcomes, this research will provide opportunity for earlier intervention, improved
individual and family functioning and a reduction of the negative impact of problem gambling
on the community.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | April 15, 2012 |
Est. primary completion date | April 15, 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Concerned Significant Other (CSO) must have a significant relationship with the Individuals Engaged in Problem Gambling (IPG)(e.g. parent, child, sibling, friend, partner). 2. CSO must have face-to-face contact with the IPG at least 3 days per week and for at least 1 hour per day with no anticipated relationship change (e.g. separation) over the next 90 days. 3. Impaired functioning of the CSO consequential to their significant other being engaged in problem gambling. 4. Evidence (from the CSOs) that the IPG meets Canadian Problem Gambling Index (CPGI) criteria for problem gambling. 5. The CSO's primary motivation for treatment is to influence their IPG's gambling behaviour. Exclusion Criteria: 1. CSO meets CPGI criteria for having problem gambling. 2. CSO has a condition, including substance dependency and/or significant psychopathology, which could impede the CSO's ability to understand and participate in treatment. 3. The IPG has received treatment for problem gambling in the previous 3 months, is currently willing to receive treatment, or has been court ordered to receive treatment. 4. Domestic violence is a significant risk based on the CSOs report and psychometric measure. 5. The CSO is currently receiving psychotherapy for issues related to their IPG's gambling. |
Country | Name | City | State |
---|---|---|---|
Canada | Addiction Services | Amherst | Nova Scotia |
Canada | Addiction Services | Pictou | Nova Scotia |
Canada | Addictions Services | Truro | Nova Scotia |
Lead Sponsor | Collaborator |
---|---|
Colchester East Hants Health Authority | Dalhousie University, Pictou County Health Authority, University of Calgary |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Concerned Significant Other Status (Quality of Life) | Measured through the following Tests: Beck Depression Inventory (Beck, Steer & Garbin 1988) State/Trait Anxiety Inventory (Speilberger 1999) State-trait Anger Expression Inventory-II (Speilberger et al. 1988) DSM -IV Screening Questionnaire; Social functioning and Resources Scale (Moos et al 1987) Physical symptoms (Moos et al 1987) |
Baseline: At 0 weeks | |
Secondary | Concerned Significant Other Status (Quality of Life) | Measured through the following Tests: Beck Depression Inventory (Beck, Steer & Garbin 1988) State/Trait Anxiety Inventory (Speilberger 1999) State-trait Anger Expression Inventory-II (Speilberger et al. 1988) DSM -IV Screening Questionnaire; Social functioning and Resources Scale (Moos et al 1987) Physical symptoms (Moos et al 1987) Significant Other Status (Quality of Life) |
Post treatment: 1 week | |
Secondary | Concerned Significant Other Status (Quality of Life) | Measured through the following Tests: Beck Depression Inventory (Beck, Steer & Garbin 1988) State/Trait Anxiety Inventory (Speilberger 1999) State-trait Anger Expression Inventory-II (Speilberger et al. 1988) DSM -IV Screening Questionnaire; Social functioning and Resources Scale (Moos et al 1987) Physical symptoms (Moos et al 1987) |
Follow up: 9 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02590211 -
Poker, Skills and Associated Problems
|
N/A | |
Completed |
NCT02203786 -
D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement
|
Phase 2 | |
Completed |
NCT05051085 -
Feasibility of the Internet-delivered Treatment "SpilleFri" for Patients With Pathological Gambling
|
N/A | |
Completed |
NCT01215357 -
Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble
|
Phase 2 | |
Terminated |
NCT00245583 -
Topiramate in the Treatment of Pathological Gambling
|
Phase 3 | |
Completed |
NCT04842461 -
Mental Health, Addictions and Biomarkers in High Athletes Performance
|
||
Not yet recruiting |
NCT03280966 -
Effects of Intranasal Naloxone on Gambling Urges in Gambling Disorder
|
Phase 2 | |
Active, not recruiting |
NCT01743092 -
Testing Resources: Manual and Webinar Guided Treatment vs. Manual Guided Treatment
|
N/A | |
Active, not recruiting |
NCT01528982 -
Susceptibility to Pathological Gambling
|
N/A | |
Terminated |
NCT00211822 -
Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD)
|
N/A | |
Completed |
NCT01381250 -
Effects of Internet-based Treatment of Pathological Gambling
|
N/A | |
Completed |
NCT05506384 -
Treatment Study for Problematic Gaming and Gambling
|
N/A | |
Enrolling by invitation |
NCT03464838 -
Effects of Transcranial Direct Current Stimulation (tDCS) in Gambling Disorder
|
N/A | |
Terminated |
NCT01560351 -
Repeated Low-frequency Transcranial Magnetic Stimulation Reduces Cue-induced Craving: a Randomized, Prospective, Double-blind, Sham-controlled, Cross-over Study
|
N/A | |
Completed |
NCT00580567 -
Impulsivity in Pathological Gambling
|
N/A | |
Completed |
NCT02240485 -
Integrative Couple Treatment for Pathological Gambling
|
N/A | |
Recruiting |
NCT02491996 -
The Efficacy of Therapy Focused on Desire-satisfaction for Disordered Gamblers
|
N/A | |
Recruiting |
NCT01154712 -
Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling
|
Phase 1 | |
Completed |
NCT00927563 -
Tolcapone Treatment of Pathological Gambling
|
Phase 2 | |
Completed |
NCT01843699 -
Topiramate Trial for Pathological Gamblers
|
Phase 2 |